ArticleCancer immunology, immunotherapy : CII2025
A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model.
Masato Saito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.